More unhealthy behaviour among young people; their health remains vulnerable Fewer young people aged 12 to 16 are positive about their health than in previous years. In addition, their mental health has not recovered after the COVID-19 pandemic.
Approach needed to tackle polluting activities to protect drinking water sources In the Netherlands, we derive our drinking water from two sources: groundwater and river water. In many areas, the quality of this water is not adequate. The measures taken to improve the quality have yet to yield significant direct effects.
295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
RIVM recommends a standardised design for e-cigarettes to reduce e-cigarette appeal Features like a sleek design, technical add-ons such as Bluetooth, and ease of concealment are examples that make e-cigarettes attractive to young people, according to research by RIVM. That is why RIVM recommends policymakers to consider implementing a standardised design for e-cigarettes
Growth of digital healthcare stabilised in 2023 The growth in the use of digital healthcare tools by care providers stabilised in 2023. This was mainly because most care providers were already using particular digital tools in 2022, such as the patient portal – on which patients can view the outcomes of examinations – and e-consultations (digital written contact with doctors).
RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
New Zoonoses Report out now: avian flu most notable outbreak in 2022 Throughout 2022, the Netherlands faced a persistent avian flu outbreak, affecting 76 poultry farms. The virus also infected numerous wild birds and various wild mammals. These findings are presented in the Zoonoses Report, an annual publication issued jointly by RIVM and the Netherlands Food and Consumer Product Safety Authority (NVWA).
No changes to chromium (VI) adverse health effect list No changes will be made to the list of adverse health effects that may be caused by exposure to chromium (VI) in the workplace. According to RIVM, the latest scientific literature has resulted in no new insights.
Gastrointestinal symptoms on the rise, but still fewer than before the COVID-19 pandemic In 2022, the number of enteric infections – which mainly cause gastrointestinal symptoms – was higher than it was in the previous two years. However, the total number of infections was still lower than before the coronavirus pandemic.
RIVM creates risk assessment toolbox to assess local groundwater quality RIVM has developed the Groundwater Risk Assessment Toolbox. This risk assessment toolbox allows local authorities to quickly determine whether a specific groundwater application is safe. They can then take action if necessary.